| BRENSOCATIB 
| BRENSOCATIB | RESPIRATORY DIPEPTIDYL PEPTIDASE 1 (DPP1) INHIBITOR TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | ORAL | Cmax 616 NANOMOLAR Tmax 1.2 HOUR F 80 PERCENT VD 132 LITER PPB 87.2 PERCENT Cl 8.5 LITER / HOUR HT 32 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE AT PH 6.8 IN WATER | DIPEPTIDYL PEPTIDASE 1 (DPP1) | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |